CZ299701B6 - Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek - Google Patents
Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek Download PDFInfo
- Publication number
- CZ299701B6 CZ299701B6 CZ20021562A CZ20021562A CZ299701B6 CZ 299701 B6 CZ299701 B6 CZ 299701B6 CZ 20021562 A CZ20021562 A CZ 20021562A CZ 20021562 A CZ20021562 A CZ 20021562A CZ 299701 B6 CZ299701 B6 CZ 299701B6
- Authority
- CZ
- Czechia
- Prior art keywords
- treosulfan
- use according
- conditioning
- bone marrow
- body surface
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19953517A DE19953517C1 (de) | 1999-11-05 | 1999-11-05 | Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ20021562A3 CZ20021562A3 (cs) | 2002-10-16 |
| CZ299701B6 true CZ299701B6 (cs) | 2008-10-22 |
Family
ID=7928187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20021562A CZ299701B6 (cs) | 1999-11-05 | 2000-11-03 | Použití treosulfanu jako prostredku upravujícího predoperacní stav pacienta pred transplantací kostní drene nebo transplantací krevních kmenových bunek |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7199162B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1227808B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4846151B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE251455T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU777527B2 (cg-RX-API-DMAC7.html) |
| BG (1) | BG65845B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2389896C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ299701B6 (cg-RX-API-DMAC7.html) |
| DE (2) | DE19953517C1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA004543B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2208435T3 (cg-RX-API-DMAC7.html) |
| HU (2) | HU227332B1 (cg-RX-API-DMAC7.html) |
| NO (2) | NO329616B1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL212132B1 (cg-RX-API-DMAC7.html) |
| UA (1) | UA73961C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001032154A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237146A1 (de) * | 2002-08-13 | 2004-03-04 | Medac Gesellschaft für klinische Spezialpräparate mbH | Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose |
| JP7431815B2 (ja) * | 2018-09-26 | 2024-02-15 | メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク | トレオスルファンの結晶形 |
| PT4257122T (pt) | 2018-09-26 | 2026-06-08 | Medac Ges Fr Klinische Spezialprparate Mbh | Liofilizado de treossulfano |
| EP3856252A1 (en) | 2018-09-26 | 2021-08-04 | medac Gesellschaft für klinische Spezialpräparate mbH | Solution comprising treosulfan |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
| US5830473A (en) * | 1994-06-18 | 1998-11-03 | Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh | Antibodies against T cells as therapeutics |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000045842A2 (en) * | 1999-02-04 | 2000-08-10 | The General Hospital Corporation | Methods for human allografting |
-
1999
- 1999-11-05 DE DE19953517A patent/DE19953517C1/de not_active Expired - Lifetime
-
2000
- 2000-03-11 UA UA2002054343A patent/UA73961C2/uk unknown
- 2000-11-03 JP JP2001534359A patent/JP4846151B2/ja not_active Expired - Fee Related
- 2000-11-03 DE DE50004024T patent/DE50004024D1/de not_active Expired - Lifetime
- 2000-11-03 PL PL356240A patent/PL212132B1/pl unknown
- 2000-11-03 EA EA200200535A patent/EA004543B1/ru not_active IP Right Cessation
- 2000-11-03 ES ES00975995T patent/ES2208435T3/es not_active Expired - Lifetime
- 2000-11-03 CZ CZ20021562A patent/CZ299701B6/cs not_active IP Right Cessation
- 2000-11-03 AT AT00975995T patent/ATE251455T1/de not_active IP Right Cessation
- 2000-11-03 US US10/129,352 patent/US7199162B1/en not_active Expired - Lifetime
- 2000-11-03 AU AU13918/01A patent/AU777527B2/en not_active Expired
- 2000-11-03 CA CA002389896A patent/CA2389896C/en not_active Expired - Lifetime
- 2000-11-03 WO PCT/EP2000/010871 patent/WO2001032154A2/de not_active Ceased
- 2000-11-03 HU HU0203277A patent/HU227332B1/hu active Protection Beyond IP Right Term
- 2000-11-03 EP EP00975995A patent/EP1227808B1/de not_active Expired - Lifetime
-
2002
- 2002-05-02 NO NO20022109A patent/NO329616B1/no not_active IP Right Cessation
- 2002-06-04 BG BG106772A patent/BG65845B1/bg unknown
-
2019
- 2019-07-23 NO NO2019032C patent/NO2019032I1/no unknown
- 2019-09-18 HU HUS1900041 patent/HUS1900041I1/hu unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
| US5830473A (en) * | 1994-06-18 | 1998-11-03 | Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh | Antibodies against T cells as therapeutics |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2389896A1 (en) | 2001-05-10 |
| ATE251455T1 (de) | 2003-10-15 |
| CZ20021562A3 (cs) | 2002-10-16 |
| BG65845B1 (bg) | 2010-03-31 |
| EP1227808B1 (de) | 2003-10-08 |
| NO2019032I1 (no) | 2019-07-23 |
| DE50004024D1 (de) | 2003-11-13 |
| EP1227808A2 (de) | 2002-08-07 |
| AU1391801A (en) | 2001-05-14 |
| WO2001032154A2 (de) | 2001-05-10 |
| DE19953517C1 (de) | 2001-08-09 |
| NO20022109L (no) | 2002-07-01 |
| US7199162B1 (en) | 2007-04-03 |
| PL212132B1 (pl) | 2012-08-31 |
| NO329616B1 (no) | 2010-11-22 |
| ES2208435T3 (es) | 2004-06-16 |
| EA004543B1 (ru) | 2004-06-24 |
| AU777527B2 (en) | 2004-10-21 |
| HUP0203277A2 (en) | 2003-01-28 |
| PL356240A1 (en) | 2004-06-28 |
| BG106772A (bg) | 2003-02-28 |
| NO20022109D0 (no) | 2002-05-02 |
| CA2389896C (en) | 2007-04-10 |
| UA73961C2 (uk) | 2005-10-17 |
| WO2001032154A3 (de) | 2002-01-24 |
| JP2003513034A (ja) | 2003-04-08 |
| JP4846151B2 (ja) | 2011-12-28 |
| EA200200535A1 (ru) | 2002-10-31 |
| HU227332B1 (en) | 2011-03-28 |
| HUS1900041I1 (hu) | 2019-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Capizzi | The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (ethyol®) | |
| JP7776435B2 (ja) | シクロフィリン阻害剤およびその使用 | |
| EP2143429B1 (en) | Use of cilastatin to reduce the nephrotoxicity of different compounds | |
| CN1225287C (zh) | 稳定的放射性药物组合物 | |
| EP0344880B1 (en) | Pharmaceutical compositions with anti-cancer activity | |
| UA127738C2 (uk) | Проліки дантролену і способи їх застосування | |
| WO2021190603A1 (en) | Cyclophilin inhibitors and uses thereof | |
| Upadhyay et al. | Chemical radioprotectors | |
| KR20130118981A (ko) | 다형 교모세포종의 치료를 위한 마시텐탄 포함 조합물 | |
| CN100479814C (zh) | 促淋巴细胞归巢剂在制备用于治疗移植物功能恢复延迟的药物中的用途 | |
| CZ20021562A3 (cs) | Pouľití treosulfanu jako prostředku upravujícího předoperační stav pacienta před transplantací kostní dřeně nebo transplantací krevních kmenových buněk | |
| MX2012000303A (es) | Composiciones farmaceuticas y metodos teraputicos que emplean una combinacion de un compuesto complejo de manganeso y una forma compleja no de manganeso del compuesto. | |
| KR20040038984A (ko) | 암 치료 방법 및 암 치료용 조성물 | |
| US20040072801A1 (en) | Sterols bearing pendant allosteric effectors of hemoglobin, and uses thereof | |
| WO2000043403A1 (en) | 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes | |
| RU2123348C1 (ru) | Противолучевое средство | |
| JPH08509961A (ja) | 低密度リポタンパク質および細胞毒性物質の使用 | |
| CN102614180A (zh) | 伊曲康唑在制备治疗多发性骨髓瘤药物中的应用 | |
| Ozturk et al. | Acute myeloblastic leukemia achieving complete remission with amifostine alone | |
| Hess et al. | Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease. | |
| WO2025141294A1 (en) | Novel hydrogen sulfide releasing compounds | |
| Parsons | Non-Immunophilin-Related Immunosuppressants | |
| Renešová | Cyclophosphamide effects on hematopoiesis | |
| US20030228253A1 (en) | Radiolabelled thioplatin, compositions thereof and methods of cancer treatment | |
| Gulati | Pharmacological mechanisms in the cardiovascular effects of DCLHb, a hemoglobin based blood substitute |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Effective date: 20251103 |